Equibles does not estimate personal net worth.
Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.
Get TEVA alertsThe proxy statement of Teva Pharmaceutical Industries Ltd reports total compensation of $6,298,933 for Dr. Eric A. Hughes in fiscal 2025, including a base salary of $829,231. Disclosed compensation is on record for 2 fiscal years. Dr. Eric A. Hughes has spoken on 1 earnings call across 1 company, most recently for Teva Pharmaceutical Industries Ltd on April 29, 2026. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 6 others.
“And as Richard mentioned, I do like to talk about this slide for two good reasons. One, there's a big impact we can make for patients across a number of different indications.”
Proxy statement
Start not stated–present
Last confirmed March 31, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, Global R&D and Chief Medical Officer | $829,231 | $6,298,933 |
| 2024 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, Global R&D and Chief Medical Officer | $753,846 | $5,754,787 |
